Category - Markets

H.C. Wainwright has upgraded Cesca Therapeutics (NASDAQ:KOOL) to “buy” from “neutral” with a new 12-month target price of $2 based on a discounted earnings/revenues analysis. The stock closed at 67 cents on Friday...